Prescription medications are a critical part of modern healthcare. When properly designed, tested, manufactured, labeled, and monitored, they can treat serious conditions, improve quality of life, and save lives. But when a drug carries risks that are not adequately studied, disclosed, or warned about, patients may suffer life-changing injuries they never knew were possible.
Pharmaceutical litigation involves claims against drug manufacturers and related companies when a medication causes serious harm. These cases are often complex, which is why the team at CPY Law is here to help you and your loved ones take on the drug companies.
You pay nothing unless we win. Focus on getting better while we handle the fight ahead. For a free consultation with our pharmaceutical litigation attorneys in Kansas City, MO, contact our law firm today.
How Dangerous Drug Claims Arise
Most prescription drugs go through years of development, testing, and regulatory review before they are sold to the public. Even so, serious safety problems may not become fully apparent until after a drug is prescribed to a much larger patient population.
Clinical trials are important, but they have limitations. They may involve a limited number of participants, may exclude certain high-risk patients, and may not be large enough or long enough to detect uncommon but serious injuries.
Common Reasons for Dangerous Drug Claims
Some risks only become clear after a drug has been used by thousands or millions of people in real-world conditions. Dangerous drug claims may arise when evidence suggests that a manufacturer:
- Failed to adequately study a known or suspected risk
- Failed to warn doctors or patients about a serious side effect
- Minimized or delayed disclosure of safety concerns
- Marketed the drug in a way that overstated benefits or understated risks
- Failed to update warnings after receiving adverse event reports
- Promoted use of the drug for patients who faced increased risk
- Failed to properly manufacture or inspect the medication
These cases often ask whether the manufacturer acted reasonably in designing, testing, labeling, marketing, and monitoring the drug. When you meet with our Kansas City pharmaceutical injury lawyers, we’ll carefully evaluate your claim and let you know what steps we’ll take next.
What Makes Pharmaceutical Litigation Different Than Personal Injury Cases
Pharmaceutical litigation differs from many other personal injury cases because the evidence often extends far beyond the individual client’s medical records. A dangerous drug case may require analysis of:
- FDA approval history
- Labeling changes
- Internal company safety data
- Clinical trial results
- Published medical studies
- Adverse event reporting
- Marketing materials
- Sales representative communications
- Expert testimony
- National litigation developments
These cases also often involve powerful defendants with substantial legal and scientific resources. Drug manufacturers typically defend these cases aggressively, often challenging general causation, specific causation, warnings, reliance, damages, and the admissibility of expert testimony.
FDA Approval and Its Limitations on Pharmaceutical Litigation
Many people assume that if a drug was approved by the FDA, it must be completely safe. That is not how the system works.
FDA approval generally means the agency determined, based on the information available at the time, that the drug’s benefits outweighed its known risks for the approved use. It does not mean the drug has no risks. It also does not mean every possible risk has been discovered.
Safety Issues for Medications Following Initial FDA Approval
After approval, manufacturers remain responsible for monitoring safety data, reviewing adverse event reports, evaluating new studies, and updating warnings when appropriate. A drug’s safety profile can change over time as more information becomes available.
This is why some medications receive updated warnings years after approval. In more serious situations, a drug may receive a black box warning, usage restrictions, or be withdrawn from the market altogether.
FDA history can be important evidence in a dangerous drug case. Our Kansas City pharmaceutical litigation lawyers may review approval materials, labeling changes, adverse event data, communications with regulators, post-market studies, and internal company records to determine whether important safety information was properly disclosed.
Failure to Warn Claims in Pharmaceutical Litigation
Failure to warn is one of the most common theories in pharmaceutical litigation.
Prescription drug manufacturers have a duty to provide adequate warnings about known or reasonably knowable risks. These warnings are typically directed to prescribing physicians through the drug’s label, prescribing information, medication guides, and other communications.
When a Warning Label May Be Inadequate
A warning may be inadequate if it:
- Fails to identify a serious risk
- Minimizes the severity of a known risk
- Omits important information about who is most vulnerable
- Fails to explain symptoms that require immediate medical attention
- Does not reflect updated safety information
- Is buried in technical language that does not adequately communicate the danger
In many cases, the issue is not just a failure to include a warning on the label. The issue is whether the warning was strong enough, clear enough, and timely enough to allow doctors and patients to make informed decisions.
Defective Drug Design in Pharmaceutical Litigation
Some pharmaceutical cases involve allegations that the drug itself was defectively designed.
A design defect claim may allege that a medication’s chemical formulation, mechanism of action, dose, delivery system, or risk profile made it unreasonably dangerous when compared with available alternatives.
These claims can be scientifically challenging. They often require expert testimony regarding pharmacology, toxicology, epidemiology, and medical causation.
Key Safety Questions for Medication Design
Design defect claims may ask questions such as:
- Did the drug create risks that outweighed its benefits for certain patients?
- Were safer alternative designs or formulations available?
- Did the manufacturer ignore evidence that the drug’s mechanism could cause serious harm?
- Were patients exposed to unnecessary risks when safer treatment options existed?
- Should the drug have been contraindicated for certain populations?
Not every pharmaceutical injury creates a design defect claim. Many drugs carry serious but known risks. The legal question is whether the medication was unreasonably dangerous under the applicable law and facts.
Manufacturing Defects in Pharmaceutical Litigation
A manufacturing defect occurs when a drug is not made according to its intended design or specifications.
Unlike a design defect, which challenges the product’s intended formulation, a manufacturing defect focuses on an error in the production process.
Examples may include:
- Contamination during manufacturing
- Incorrect dosage strength
- Improper mixing of ingredients
- Foreign substances in the medication
- Failure to follow quality control procedures
- Packaging or labeling mistakes
- Storage or distribution problems that affect drug stability
Manufacturing defect cases may involve batch records, plant inspections, recall notices, quality control documents, and testing data.
These cases can be narrower than large-scale pharmaceutical mass torts, but they can still cause serious harm when contaminated or improperly manufactured medications reach patients.
Misleading Marketing and Overpromotion in Pharmaceutical Litigation
Pharmaceutical companies may also face liability when marketing materials, sales practices, or communications to healthcare providers allegedly misrepresent a drug’s safety or effectiveness.
In some cases, the marketing history of a drug becomes central to the litigation because it helps show how the manufacturer communicated risk information to doctors and the public.
Examples of Misleading Marketing for Medications
Marketing issues can arise when a company:
- Overstates the benefits of a medication
- Downplays known risks
- Promotes use in patient populations not adequately studied
- Encourages use beyond the approved indication
- Provides incomplete safety information to prescribing physicians
- Fails to disclose emerging risk signals
Our pharmaceutical litigation attorneys in Kansas City can review all of a drug company’s marketing and promotional materials to help strengthen your claim.
Post-Market Surveillance in Pharmaceutical Litigation
Drug safety does not end when a medication is approved. Manufacturers are expected to monitor safety information after the drug reaches the market. This process is commonly referred to as post-market surveillance.
How Drug Companies Are Expected to Monitor Safety
Post-market information may include:
- Adverse event reports
- Published medical literature
- Internal safety analyses
- Regulatory communications
- Physician reports
- Patient complaints
- Foreign regulatory actions
- New clinical or observational studies
In many pharmaceutical cases, plaintiffs allege that the manufacturer received safety signals but failed to act quickly enough. Those allegations may include failure to conduct additional studies, failure to update warnings, or failure to alert physicians about newly discovered risks.
Common Injuries in Pharmaceutical Litigation
The injuries involved in pharmaceutical cases vary widely depending on the medication and the alleged defect. Claims may involve:
- Cancer
- Blood clots
- Stroke
- Heart attack
- Kidney damage
- Liver damage
- Vision loss
- Gastrointestinal injuries
- Neurological injuries
- Birth defects
- Hormonal injuries
- Severe allergic or immune reactions
- Infection
- Psychiatric or cognitive complications
- Wrongful death
The existence of a known side effect does not automatically mean a legal claim exists. A viable claim generally requires evidence connecting the medication to the injury and showing that the manufacturer may be legally responsible.
Evidence Needed to Evaluate a Dangerous Drug Claim
Pharmaceutical cases are evidence-driven. Before a claim can be pursued over a dangerous drug, our Kansas City attorneys typically need to evaluate medical records and product-use history carefully.
Important evidence may include:
- Pharmacy records showing when the medication was filled
- Prescribing physician records
- Primary care records
- Specialist records
- Hospital records
- Surgical records
- Pathology reports
- Imaging studies
- Lab results
- Diagnosis records
- Records showing when symptoms began
- Prior medical history
- Information about other medications or risk factors
This information helps determine whether the client used the drug during the relevant time period, whether the alleged injury matches the litigation criteria, and whether other medical explanations may affect causation.
Causation in Pharmaceutical Cases
Causation is often one of the most contested issues in pharmaceutical litigation.
It is usually not enough to show that a person took medication and later developed an injury. The legal and medical analysis must address whether the drug was capable of causing the injury and whether it likely caused or contributed to the injury in that particular person.
Two Key Questions About Causation in Dangerous Drug Litigation
This often involves two related questions.
- Can the drug cause the injury generally?
- Did the drug cause this client’s injury specifically?
The first question may involve medical literature, epidemiology, biological plausibility, regulatory findings, and expert testimony.
The second question may involve the client’s dose, duration of use, timing of symptoms, medical history, other risk factors, and treating physician opinions.
Because causation can be complicated, early case screening is important. It helps clients understand whether their claim appears to fit the evidence and avoids creating unrealistic expectations.
The Deadline to File a Pharmaceutical Injury Lawsuit in Missouri
The statute of limitations for pharmaceutical injury claims in Missouri is typically five years from the date of injury or illness (RSMo § 516.120).
If the use of a dangerous medication resulted in the death of a loved one, you have three years from the death of your loved one to file a wrongful death lawsuit (RSMo § 537.100).
Do not delay. It’s best to speak with our Kansas City pharmaceutical injury attorneys as soon as possible. Your lawyer can let you know if you have a valid claim and what steps to take next.
How CPY Law Helps Clients in Pharmaceutical Litigation
At CPY Law, our work begins with listening. We want to understand what medication the client used, why it was prescribed, when it was taken, what injury occurred, and how that injury affected the client’s life.
From there, we focus on gathering and evaluating the evidence needed to determine whether the claim can be pursued. Our work may include:
- Reviewing medical and pharmacy records
- Evaluating product use and timing
- Determining whether the injury matches known litigation criteria
- Monitoring national litigation developments
- Coordinating with litigation leadership when appropriate
- Communicating with clients about significant updates
- Helping clients understand the process and potential timelines
- Preparing claims for litigation, settlement, or trial when appropriate
For our Kansas City dangerous drug attorneys, our goal is to provide clear, honest guidance and individualized representation throughout the litigation process.
Contact Our Kansas City Pharmaceutical Litigation Lawyers Near You
If you believe you were seriously injured by a prescription medication, CPY Law can help you understand your options. Let us handle the fight while you focus on healing. For a free case review with our pharmaceutical litigation attorneys, contact our Kansas City law firm today.
Frequently Asked Questions About Pharmaceutical Litigation in Kansas City
Below are some of the most common questions we’ve heard from clients during pharmaceutical litigation cases.
Does FDA approval mean I do not have a case?
No. FDA approval does not automatically prevent a lawsuit. Manufacturers may still be responsible if evidence shows they failed to provide adequate warnings, withheld important safety information, failed to update labeling, or otherwise acted improperly under the law.
What if my doctor prescribed the medication that harmed me?
A doctor’s prescription does not necessarily eliminate a claim against the drug manufacturer. Many pharmaceutical cases focus on whether the manufacturer gave adequate information to healthcare providers so they could properly weigh the risks and benefits of the drug.
What if the medication label listed my injury as a possible side effect? Can I still file a lawsuit?
That depends. The question may be whether the warning was adequate, timely, clear, and strong enough under the circumstances. The mere existence of some warning does not always end the analysis.
Our Kansas City pharmaceutical litigation lawyers can review the details of your case and let you know if you still have a valid claim.
How do I know if my injury is related to the medication I took?
That requires a review of your medication history, medical records, timing of symptoms, diagnosis, and known scientific evidence. In many cases, expert review is also necessary.
Are dangerous drug cases class actions?
Usually not. Most serious drug injury cases proceed as individual claims within a mass tort or MDL because each person’s medical history, injury, treatment, and damages are different.
How long does pharmaceutical litigation take?
Timelines vary. Some cases resolve relatively quickly, while others take several years. The timing depends on the litigation stage, discovery, court rulings, expert evidence, bellwether trials, settlement negotiations, and the facts of the individual claim.
Will I have to go to trial for my pharmaceutical case?
Many pharmaceutical cases resolve before trial, but trial is always possible. Whether a particular case proceeds to trial depends on the litigation, the evidence, settlement opportunities, and strategic decisions made as the case develops.
What documents should I keep?
You should keep medication bottles, pharmacy printouts, prescription records, medical records, discharge paperwork, diagnosis records, photographs, correspondence, and any documents related to your injury or treatment. Do not throw away potential evidence.
